Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TPMT | P51580 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | TTR | P02766 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ACP1 | P24666 | 1/20 | 0.32 |
| ▸ | GSK3B | P49841 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL913884 | 0.94 | TPMT (0.35) | TPMTALDH1A1CA1CA2TTR | |
| SCHEMBL3397238 | 0.84 | PARP1 (0.32) | — | |
| SCHEMBL5225566 | 0.79 | TTR (0.41) | CA1CA2TTRGSK3B | |
| SCHEMBL5227070 | 0.79 | CA1 (0.48) | ALDH1A1CA1CA2TSHR | |
| SCHEMBL5227982 | 0.79 | CES2 (0.50) | — | |
| SCHEMBL38576 | 0.78 | ALDH1A1 (0.40) | TPMTALDH1A1CA1CA2TTR | |
| SCHEMBL4265740 | 0.76 | TPMT (0.61) | TPMTALDH1A1TSHR | |
| Hydrochloric Acid SCHEMBL18918955 | 0.76 | ALDH1A1 (0.39) | TPMTALDH1A1CA1CA2TTR | |
| SCHEMBL40374 | 0.75 | ALDH1A1 (0.50) | ALDH1A1TSHR | |
| SCHEMBL29439753 | 0.75 | ALDH1A1 (0.50) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113995884-A | Liquid embolic agent and preparation method thereof | 苏州浩微生物医疗科技有限公司 | 2022-02-01 | — | — | CN | claimed |
| CN-113995884-A | Liquid embolic agent and preparation method thereof | 苏州浩微生物医疗科技有限公司 | 2022-02-01 | — | — | CN | disclosed |